TriSalus Life Sciences, Inc.
TLSI
$5.73
$0.081.42%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -10.11M | -2.39M | -4.33M | -13.22M | -35.64M |
| Total Depreciation and Amortization | 193.00K | 169.00K | 194.00K | 188.00K | 194.00K |
| Total Amortization of Deferred Charges | 178.00K | 167.00K | 267.00K | -- | -- |
| Total Other Non-Cash Items | 3.56M | -5.64M | -3.17M | 2.65M | 22.37M |
| Change in Net Operating Assets | 467.00K | -3.15M | -6.38M | -483.00K | 3.90M |
| Cash from Operations | -5.71M | -10.85M | -13.42M | -10.87M | -9.18M |
| Capital Expenditure | -50.00K | -169.00K | -60.00K | -66.00K | -372.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -1.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 1.00M |
| Cash from Investing | -50.00K | -169.00K | -60.00K | -66.00K | -372.00K |
| Total Debt Issued | 0.00 | 0.00 | 25.00M | -- | -- |
| Total Debt Repaid | -19.00K | -22.00K | -21.00K | -22.00K | -22.00K |
| Issuance of Common Stock | 3.01M | 5.85M | 3.61M | 3.15M | 85.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -2.59M | -- | -20.00K |
| Cash from Financing | 2.99M | 5.82M | 25.99M | 3.13M | 43.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.76M | -5.19M | 12.51M | -7.81M | -9.51M |